160 related articles for article (PubMed ID: 33752525)
1.
Liu J; Li Y; Zhang Q; Lv C; Wang M; Jiao Y; Wang C
Technol Cancer Res Treat; 2021; 20():1533033820971610. PubMed ID: 33752525
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
Yang J; Li C; Mudd A; Gu X
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.
He RQ; Qin MJ; Lin P; Luo YH; Ma J; Yang H; Hu XH; Chen G
Cell Physiol Biochem; 2018; 46(2):591-608. PubMed ID: 29617692
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of LncRNA PVT1 Predicts Advanced Clinicopathological Features and Serves as an Unfavorable Risk Factor for Survival of Patients with Gastrointestinal Cancers.
Liu F; Dong Q; Huang J
Cell Physiol Biochem; 2017; 43(3):1077-1089. PubMed ID: 28968599
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
10. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.
Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN
J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787
[TBL] [Abstract][Full Text] [Related]
11. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the expression of long non-coding RNA PVT1 in glioma.
Fang J; Huang J
Cancer Biomark; 2019; 24(4):509-513. PubMed ID: 30909189
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
[TBL] [Abstract][Full Text] [Related]
14. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer.
Shao N; Zhu Y; Wan FN; Ye DW
Asian J Androl; 2019; 21(6):618-622. PubMed ID: 30860081
[TBL] [Abstract][Full Text] [Related]
15. PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.
Videira A; Beckedorff FC; daSilva LF; Verjovski-Almeida S
Cell Commun Signal; 2021 Jan; 19(1):5. PubMed ID: 33430890
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer.
Li B; Guo LH; Ban ZQ; Liu L; Luo L; Cui TY
Medicine (Baltimore); 2020 Jul; 99(28):e21059. PubMed ID: 32664121
[TBL] [Abstract][Full Text] [Related]
19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients.
Huang C; Yu W; Wang Q; Cui H; Wang Y; Zhang L; Han F; Huang T
Minerva Med; 2015 Jun; 106(3):143-9. PubMed ID: 25668599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
